IL2 and Rapamycin Enhance Persistence of Adoptively-Transferred Ex-Vivo Expanded T Regulatory Cells

被引：0
|
作者：
Furlan, Scott N. [1 ]
Lopez, Christina [1 ]
Tkachev, Victor [2 ]
Betz, Kayla [2 ]
Hunt, Daniel J. [3 ]
Hibbard, James [4 ]
Blazar, Bruce R. [5 ]
Trapnell, Cole [6 ]
Kean, Leslie [2 ]
机构：
[1] Seattle Childrens Res Inst, Ben Towne Ctr Childhood Canc Res, Seattle, WA USA
[2] Boston Childrens Hosp, Boston, MA USA
[3] Harvard Med Sch, Dept Pediat, Boston, MA USA
[4] Seattle Childrens Res Inst, Seattle, WA USA
[5] Univ Minnesota, Div Pediat Blood & Marrow Transplantat, Minneapolis, MN USA
[6] Univ Washington, Sch Med, Genome Sci, Seattle, WA USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-120254
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2049
引用
收藏
页数：3
相关论文
共 50 条
  • [21] ADOPTIVELY TRANSFERRED EX-VIVO ACTIVATED MEMORY T-CELLS WITH CYCLOPHOSPHAMIDE - EFFECTIVE TUMOR-SPECIFIC CHEMOIMMUNOTHERAPY OF ADVANCED METASTATIC MURINE MELANOMA AND CARCINOMA
    GOLD, JE
    ZACHARY, DT
    OSBAND, ME
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1994, 73 (01): : 115 - 122
  • [22] Repertoire analysis of ex vivo polyclonally expanded regulatory T cells.
    Zilberberg, Jenny
    Goldgirsh, Kira
    Komgold, Robert
    Friedman, Thea M.
    BLOOD, 2006, 108 (11) : 919A - 920A
  • [23] Enhanced Lymphodepletion Is Insufficient to Replace Exogenous IL2 or IL15 Therapy in Augmenting the Efficacy of Adoptively Transferred Effector CD8+ T Cells
    Johnson, C. Bryce
    May, Bennett R.
    Riesenberg, Brian P.
    Suriano, Samantha
    Mehrotra, Shikhar
    Garrett-Mayer, Elizabeth
    Salem, Mohamed L.
    Jeng, Emily K.
    Wong, Hing C.
    Paulos, Chrystal M.
    Wrangle, John M.
    Cole, David J.
    Rubinstein, Mark P.
    CANCER RESEARCH, 2018, 78 (11) : 3067 - 3074
  • [24] Bortezomib Treatment to Potentiate the Anti-tumor Immunity of Ex-vivo Expanded Adoptively Infused Autologous Natural Killer Cells
    Lundqvist, Andreas
    Berg, Maria
    Smith, Aleah
    Childs, Richard W.
    JOURNAL OF CANCER, 2011, 2 : 383 - 385
  • [25] In vivo prevention of transplant arteriosclerosis by ex vivo-expanded human regulatory T cells
    Nadig, Satish N.
    Wieckiewicz, Joanna
    Wu, Douglas C.
    Warnecke, Gregor
    Zhang, Wei
    Luo, Shiqiao
    Schiopu, Alexandru
    Taggart, David P.
    Wood, Kathryn J.
    NATURE MEDICINE, 2010, 16 (07) : 809 - U112
  • [26] Induced Regulatory T Cells Promote Tolerance When Stabilized by Rapamycin and IL-2 In Vivo
    Zhang, Ping
    Tey, Siok-Keen
    Koyama, Motoko
    Kuns, Rachel D.
    Olver, Stuart D.
    Lineburg, Katie E.
    Lor, Mary
    Teal, Bianca E.
    Raffelt, Neil C.
    Raju, Jyothy
    Leveque, Lucie
    Markey, Kate A.
    Varelias, Antiopi
    Clouston, Andrew D.
    Lane, Steven W.
    MacDonald, Kelli P. A.
    Hill, Geoffrey R.
    JOURNAL OF IMMUNOLOGY, 2013, 191 (10): : 5291 - 5303
  • [27] MAPC® cell therapy enhances the ex-vivo expansion of polyclonal, regulatory T cells
    Roobrouck, V.
    Beyens, J.
    Van Houtven, E.
    Reading, J.
    Hull, C.
    Tree, T.
    Lombardi, G.
    Valentin-Torres, A.
    Ting, A.
    CYTOTHERAPY, 2020, 22 (05) : S135 - S136
  • [28] Impact of immunosuppressive regimen on ex vivo expanded human regulatory T-cells
    Scotta, C.
    Fanelli, G.
    Hoong, J.
    Romano, M.
    Sukthankar, M.
    Guggino, G.
    Fazekasova, H.
    Kulachelvy, R.
    Becker, P.
    Afzali, B.
    Lechler, R.
    Lombardi, G.
    IMMUNOLOGY, 2014, 143 : 144 - 144
  • [29] Ex-vivo expanded donor-specific CD4+CD25+ regulatory T cells induce transplantation tolerance
    Golshayan, D
    Jiang, SP
    Tsang, J
    Garin, MI
    Lechler, RI
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 538 - 538
  • [30] In vivo reconstitution of human natural T regulatory cells in NOD/SCID IL2γcnull mice by expression of human IL-2
    Abraham, Sojan
    Pahwa, Rajendra
    Ye, Chunting
    Pahwa, Savita
    Jaggaiahgari, Shashidhar
    Manjunath, N.
    Shankar, Premlata
    JOURNAL OF IMMUNOLOGY, 2013, 190
12345